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Background: Accurate evaluation of adnexal masses allows correct surgical procedure,
avoiding unnecessary surgery.
Purpose: To evaluate the accuracy of magnetic resonance imaging (MRI) in the diagnosis
of malignancy of adnexal lesions.
Material and Methods: We retrospectively reviewed the pelvic MRI scans of 161 patients
with 199 surgically confirmed adnexal masses, between November 1998 and June 2005.
The criteria for adnexal malignancy were contrast-enhanced solid lesions, contrast-
enhanced solid components in mixed lesions (except those with low-signal-intensity solid
components on T2-weighted imaging [T2WI]), contrast-enhanced papillary projections
in cystic lesions (except those with low-signal-intensity papillary projections on T2WI),
or septal thickness ]3 mm. Ascites, peritoneal metastasis, and pelvic adenopathy were
also regarded as criteria for malignancy.
Results: On MRI evaluation, 97 adnexal lesions were malignant and 102 were non-
malignant. Thirty-two percent of patients with ascites had benign lesions. Histopatho-
logic evaluation of the adnexal lesions showed that 83 were malignant (true positives),
100 were non-malignant (true negatives), and seven were uncertain malignant potential
tumors; two were false negative and seven were false positive. The MRI sensitivity and
specificity for malignancy were 98% and 93%, respectively. MRI reached an accuracy of
95%, with a positive predictive value of 0.92 and a negative predictive value of 0.98 for
malignant adnexal lesions. The kappa coefficient was 0.906, indicating almost perfect
agreement between MRI and histological results.
Conclusion:MRI is an accurate method for evaluating the malignancy of adnexal lesions.
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Ovarian cancer is the second most common gyne-
cologic malignancy, and is the leading cause of
death concerning gynecologic tumors (1). The
majority of women with ovarian cancer present at
an advanced stage of disease, largely because there
are no apparent signs or symptoms at earlier stages
(1). Screening examinations, including imaging
modalities, are important for the early detection
and evaluation of adnexal lesions. As adnexal
masses are commonly found, the main goal of
imaging should be the evaluation and characteriza-
tion of the lesions in order to differentiate malig-
nant from non-malignant tumors. Transvaginal
ultrasonography (TVUS) should be the first ima-
ging approach for adnexal lesions (2), which allows
specific diagnosis in the majority of cases (3).
However, magnetic resonance imaging (MRI) is
superior in the characterization of adnexal masses
(4) and should be used to further characterize
indeterminate adnexal mass identified by US (5).
Previous imaging studies have reported accuracies
in the characterization of malignancy of adnexal
masses ranging from 60 to 95% for US (4, 6, 7) and
from 83 to 94% for MRI (3, 4, 713); the lower
figure of 83% is from a relatively early pioneer
study using older equipment (3).
ReportedMR imaging criteria for the diagnosis of
adnexal malignant tumors include mass size larger
than 4 cm, predominantly solid lesions, the pre-
sence of necrosis on contrast-enhanced solid lesions,































contrast-enhanced papillary projections, or septal
thickness ]3 mm in cystic lesions, and bilaterality
(8, 14). The presence of ascites, peritoneal metastasis,
pelvic adenopathy, and the continuous spread of the
adnexal lesion to adjacent organs or the pelvic wall
are also helpful criteria in the diagnosis of a
malignant tumor or in cases where it is suspected
(8). Adnexal lesions with signals characteristic of fat,
blood, or cyst without enhancement are reported as
benign lesions (15).
Our aim was to evaluate the accuracy of MRI in
the diagnosis of malignancy of adnexal lesions. In
order to determine the accuracy of MRI, we
classified the adnexal lesions as malignant and
non-malignant using MR, and compared this with
the final histological diagnoses.
Material and Methods
We retrospectively reviewed data concerning the
pelvic MRI exams of 161 patients with 199 adnexal
lesions that underwent surgery at our hospital
between November 1998 and June 2005. The
mean patient age was 50.5 years (range 1583
years). In this study, lesions of ovarian and extra-
ovarian origin, such as the fallopian tube and
peritoneum, were included. The vast majority of
the adnexal masses were ovarian in origin.
The pelvic MRI studies were performed, accord-
ing to the guidelines of our hospital, for the
characterization of indeterminate adnexal mass
identified by US. Patient case notes included reports
of previous US and, occasionally, clinical reports.
MRI examinations were performed using a 1.0-
Tesla superconducting unit (Gyroscan NT10; Phi-
lips Medical Systems, Eindhoven, The Netherlands)
with a pelvic phased-array coil. All examinations
were carried out according to the following imaging
protocol: T1-weighted transverse turbo spin-echo
(repetition time/echo time [TR/TE] 550/14 ms), T2-
weighted transverse and sagittal turbo spin-echo
(TR/TE 4000/90 ms), and T1-weighted transverse
turbo spin-echo sequences were carried out imme-
diately after completing the administration of 0.2
mmol/kg gadopentetate dimeglumine (Magnevist;
Schering, Berlin, Germany), with a fat-suppression
technique, a matrix of 256256, 5-mm slice thick-
ness, and 1-mm interslice gap. All transverse planes
were acquired from the aortic bifurcation to the
ischial tuberosity. If a large tumor was detected, the
pelvic MRI study was extended to the rest of the
abdomen to cover the entire lesion. Dynamic studies
were not performed.
All patients fasted for 6 hours before the exam-
ination, and 20 mg of intramuscular hyoscine
butylbromide (Buscopan; Boehringer, Germany)
was given to reduce motion artifacts by bowel
movements.
MR imaging analysis
MRI readings were carried out by a senior radi-
ologist (T.M.C.) with experience in pelvic MRI and
a radiologist in training (A.G.). All images were
saved on film, and were retrospectively reviewed
and consensually evaluated by both. All adnexal
lesions were analyzed and classified according to the
following criteria: contrast-enhanced solid lesions,
contrast-enhanced solid components in mixed le-
sions (except those with low-signal-intensity solid
components on T2-weighted images), contrast-
enhanced papillary projections in cystic lesions
(except those with low-signal-intensity papillary
projections on T2-weighted images), or septal
thickness ]3 mm. The presence of ascites, perito-
neal metastasis, and pelvic adenopathies was also an
ancillary criterion for malignancy; otherwise, lesion
size and bilaterality were not regarded as criteria for
malignancy.
Adnexal lesions were classified into three types:
cystic, solid, or mixed lesions with malignant or
non-malignant features according to the following
characteristics.
a. Lesions were considered cystic if they had low
to slightly high signal intensity on T1-weighted
images and high signal intensity on T2-
weighted images compared with urine, and
were classified as malignant cystic lesions if
there were contrast-enhanced papillary projec-
tions (Fig. 1) or septal thickness ]3 mm
(Fig. 2), except those with low-signal-intensity
papillary projections on T2-weighted images.
The identification of blood was carried out
based on signal intensity characteristics on T1-
and T2-weighted images. When a cystic lesion
had variable signal intensity on T1-weighted
images and high signal intensity on T2-
weighted images without contrast enhance-
ment, it was considered a high-protein-content
or subacute hemorrhagic cyst. The diagnosis of
endometrioma was given if the cystic lesion
had high signal intensity on T1-weighted
images with loss of signal intensity on T2-
weighted images (‘‘shading’’). The diagnosis of
a mature teratoma was given when fatty tissue
was identified.
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b. Lesions were considered solid if they had
variable signal intensity on T1- and T2-
weighted images and showed enhancement
after contrast with or without areas of necrosis.
All contrast-enhanced solid lesions were con-
sidered malignant, except those with low signal
intensity on T2-weighted images.
c. Lesions were considered mixed if they had
solid and cystic components in harmonious
portions (Fig. 3). All these lesions were
considered malignant, except those with low-
signal-intensity solid components on T2-
weighted images (Fig. 4). If the lesion had a
predominantly cystic component with a negli-
gible enhanced solid component, it was con-
sidered as cystic with papillary projection. If
the lesion had a predominantly enhanced solid
component with a negligible cystic area, it was
considered as solid with areas of necrosis/cystic
areas.
Mixed, solid, or cystic lesions with very-low-signal-
intensity solid components on T2-weighted images
(like striate muscle) were considered as benign
tumors with fibrous components (1619). Lesion
size 4 cm as a malignant criterion was not
Fig. 1. Clear-cell carcinoma. A. Large cystic right adnexal lesion with intermediate-signal-intensity solid papillary projections and a thick
septum on axial T1-weighted MR image. B. On contrast-enhanced axial T1-weighted image, the papillary projections and the septum show
contrast enhancement. C. Gross specimen section of right oophorectomy.
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included if it did not contribute to further predic-
tion of malignancy when combined with other
imaging findings (9). Neither did we use bilaterality
as a criterion of malignancy, because it occurs in
both malignant and benign lesions, and it is mainly
related to specific histological types (5, 10).
Histological analysis
Histological reports were also evaluated, and if there
was any doubt concerning the histological diagnosis,
the specimen was reviewed by a pathologist (A.F.)
with experience in gynecological pathology. Using
the World Health Organization (WHO) classifica-
tion of tumors of female genital organs (20) for the
histological diagnosis, adnexal lesions were divided
into three groups: malignant, non-malignant, and
uncertain malignant potential tumors. All malignant
neoplasms and borderline tumors were included as
malignant tumors. All benign lesions, as well as
functional ovarian cysts, peritoneal inclusion cysts,
and adnexal inflammatory lesions, were grouped and
classified as non-malignant lesions. The remaining
tumors were classified as uncertain malignant po-
tential tumors.
The MRI results (malignant/non-malignant)
were classified as correct or not correct according
to the final histological diagnoses (malignant/
Fig. 2. Mucinous borderline tumor. A. Large multiloculated right adnexal cystic mass shows heterogeneous signal intensity with thick septa
on axial T1-weighted MR image. B. On contrast-enhanced fat-suppressed axial T1-weighted image, the wall and septa of the mass show
contrast enhancement. C. Gross specimen section of right oophorectomy.
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non-malignant). All MRI and histological results
were compared, except those relating to tumors
classified as of uncertain malignant potential.
Statistical analysis
The kappa statistic was used to evaluate the degree




Based on the analysis of the imaging characteristics
of the 199 lesions, 97 adnexal lesions were char-
acterized as malignant and 102 as non-malignant.
Of these, seven lesions were excluded from the study
because they were histologically classified as un-
certain malignant potential tumors. The final
pathological report of the remaining 192 lesions
found that 83 malignant (true positive) and 100
non-malignant (true negative) lesions were correctly
diagnosed. The MRI evaluation of adnexal lesions
failed to detect malignancy in nine cases: two were
false-negative and seven were false-positive results.
On MRI evaluation of the 192 adnexal lesions, 120
lesions were found to be cystic, 33 were mixed, and
39 were solid.
Cystic lesions
Of the 120 cystic lesions, 32 were classified as
malignant and 88 as non-malignant. The vast
majority of non-malignant cystic lesions had vari-
able signal intensity on T1- and T2-weighted images
without enhanced papillary projections or thick
septa. Cystic lesions with very-low-signal-intensity
solid components on T2-weighted images (similar to
muscle) (Fig. 5) were also included in this group.
This pattern was present in six cases: five cystade-
nofibromas and one borderline cystadenofibroma
tumor.
Fig. 3. Germ-cell tumor of the right ovary in a 40-year-old woman. Large mixed mass with solid and cystic components on T1-weighted (A)
and T2-weighted (B) images. C. Contrast-enhanced T1-weighted image shows prominent enhancement of the solid component. D. Section of
part of the resected specimen with solid hemorrhagic and necrotic tumor.
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On MRI, 99% of all non-malignant cystic lesions
were histologically confirmed as benign, except
the borderline cystadenofibroma (1%). The major-
ity of the non-malignant cystic lesions were simple
hemorrhagic or high-protein-content cysts, endo-
metriomas, and teratomas.
All 32 cases of cystic lesions defined as malig-
nant by MRI (enhanced papillary projections or
enhanced thick septa) were confirmed by histology
as malignant, except for three (9%) lesions (one
benign struma ovarii, one cystadenoma associated
with benign struma ovarii, and one serous cysta-
denoma).
Solid lesions
Of the 39 adnexal masses demonstrating solid
pattern, 31 were malignant and eight were non-
malignant in the final histological diagnoses. All
five solid lesions considered as non-malignant on
MRI had a non-malignant histological diagnosis.
These lesions were three fibromas, one fibrothe-
coma, and one thecoma. In none of the malignant
lesions was this MR feature (solid lesions with low
signal intensity on T2-weighted images) found.
Four lesions (10%) with solid pattern and malig-
nant features on MRI (two fibromas and one
bilateral cystadenofibroma) were non-malignant on
histologic examination. The remaining solid lesions
were correctly diagnosed on MRI as malignant.
Fig. 4. Left adnexal fibroma in a 70-year-old woman. A. Mixed left adnexal lesion demonstrates heterogeneous signal intensity with high-
signal-intensity cystic portions and low-signal-intensity solid portions (white arrow) on axial T2-weighted MR image. B. The mass shows
enhancement of the solid portions on contrast-enhanced fat-suppressed axial T1-weighted image. C. Gross specimen section of left
oophorectomy.
Fig. 5. Bilateral cystadenofibroma of the ovary in a 77-year-old
woman. Axial T2-weighted image shows a bilateral cystic lesion with
thick and thin septations, a low-signal-intensity solid component,
and a low-signal-intensity papillary projection (arrow).
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All 21 lesions with mixed pattern and criteria of
malignancy on MRI were correctly diagnosed as
malignant. Twelve lesions with mixed pattern and
low-signal-intensity solid components on T2-
weighted images were classified as non-malignant.
Eleven (92%) were correctly diagnosed on MRI as
non-malignant (seven cystadenofibromas and four
fibromas), and one (8%) was a borderline Brenner
tumor.
Ancillary criteria
Ascites, peritoneal nodules, and pelvic adenopathies
were present in 65, 17, and eight patients, respec-
tively. All patients with pelvic adenopathies and
peritoneal metastasis had malignant adnexal
masses. Ascites was presented in 44 patients with
malignant adnexal masses and in 21 with benign
adnexal masses.
Lesions with the highest accuracy rate for the
diagnosis of malignancy achieved by MRI were
mixed lesions; these diagnoses concurred 100% with
the histological diagnoses. There were three cystic
(9%) and four solid (13%) lesions that were
histologically non-malignant, but had malignant
features on MRI.
Histological results
Using histological evaluation, 85 masses were
classified as malignant tumors (37 ovarian tumors,
16 epithelial borderline ovarian tumors [one cysta-
denofibroma, 10 epithelial serous tumors, three
epithelial mucinous tumors, one mixed tumor, and
one Brenner tumor], 26 ovarian metastases, five
primary fallopian tube carcinomas, and one carci-
noma originating from the mesosalpinx). One
hundred seven were classified as benign tumors
(94 ovarian benign tumors, seven functional cysts,
one peritoneal inclusion cyst, one cytosteatonecrosis
of an epiploic appendix, three tubo-ovarian ab-
scesses, and one hematosalpinx). Seven were classi-
fied as uncertain malignant potential tumors (one
sclerosing stromal tumor, one Sertoli-Leydig cell
tumor, one granulosa cell tumor, one stromal
endometrial tumor in an endometrioma, one steroid
cell tumor, one Leydig cell tumor, and one ovarian
Wolffian tumor).
Statistical results
A kappa coefficient of 0.906 revealed an almost
perfect agreement between MRI and the histologi-
cal results. The MRI sensitivity and specificity for
malignancy were 98% and 93%, respectively. MRI
reached an accuracy of 95%, with a positive
predictive value of 0.92 and a negative predictive
value of 0.98 for malignant adnexal lesions.
Discussion
Preoperative characterization of adnexal lesions has
important implications. Firstly, it is of considerable
value for the gynecologist or general surgeon to
know before surgery whether the lesion is benign or
malignant, as this enables them to perform the most
appropriate surgical procedure. Secondly, clinical
and laboratory data are usually not specific enough
for the characterization of the malignant nature of
these lesions, especially in premenopausal women
(9).
US and MRI are the most useful modalities for
the assessment of adnexal lesions (4). US should be
the primary imaging approach for the assessment
and characterization of adnexal lesions (2). MRI,
specifically contrast-enhanced MRI, provides addi-
tional information, mainly in the characterization of
indeterminate lesions identified by US, as contrast-
enhanced MRI is significantly more accurate than
US in adnexal lesion characterization, as shown by
previous studies (4, 11, 21). Endovenous contrast
administration is fundamental to the differentiation
between solid and cystic lesions. For this reason, it
is essential to apply the correct MRI protocol when
evaluating adnexal lesions.
In this study, we found that MRI is a reliable
method for differentiating between malignant and
non-malignant adnexal lesions with high accuracy
(95%), and our data concur with previously pub-
lished data that report accuracies ranging from 83
to 94% (3, 4, 713). The pelvic MRI scans of 161
patients with 199 adnexal lesions who underwent
surgery at our hospital were reviewed, and the MRI
and histological results were compared. Of these
lesions, seven were excluded (seven adnexal pa-
tients) because the final histological diagnosis of
these lesions was tumor with uncertain prognosis.
These tumors could not be unambiguously classified
as malignant or non-malignant, as the prognosis
was unpredictable. It is important to point out that
all these lesions had malignant features on MRI.
One hundred ninety-two adnexal lesions were hence
included, and well-established MRI criteria for
diagnosing malignancy were applied. Some modifi-
cations were introduced, such as masses with very
low signal intensity (similar to muscle striate) on
T2-weighted images, which were excluded from the
malignant group. Although the size of the lesion
(4 cm) is considered a criterion of malignancy by
Acta Radiol 2008 (6)






























some authors (8, 4, 14), it was not included as such
in our study, as we agree with others that lesion size
(4 cm) when combined with other imaging find-
ings does not further contribute to the prediction of
malignancy (9). The bilaterality of adnexal lesions is
another accepted criterion of malignancy. This
criterion was also rejected, because bilaterality can
occur in both malignant and benign lesions, and is
mainly related to specific histological types (5, 10).
Despite bilateral ovarian involvement usually re-
flecting the presence of metastases, recent studies
have shown that bilaterality is not a reliable
differentiating feature of primary versus secondary
ovarian neoplasm (22).
All lesions studied in this report with non-
malignant features on MRI were correctly diag-
nosed as non-malignant, except for two borderline
tumors (one cystic lesion with low-signal-intensity
papillary projections on T2-weighted images and
one mixed lesion with low-signal-intensity solid
components on T2-weighted images). The majority
of non-malignant lesions were cystic. Our study
shows that non-malignant simple cystic lesions were
almost all correctly diagnosed based on previously
established criteria (3, 4, 15). The identification of
blood and high protein content based on signal
intensity characteristics on T1- and T2-weighted
images contributed to the diagnosis of hemorrhagic/
high-protein-content cysts, as proven in the litera-
ture (15).
All endometriomas in this study had high signal
intensity on T1-weighted images with loss of signal
on T2-weighted images (‘‘shading’’), as already
shown by previous studies (3, 4, 15). In this series,
as in the study by TOGASHI et al. (23), no case of
malignancy was misdiagnosed as an endometrial
cyst. The diagnosis of mature teratoma was cor-
rectly made when fatty tissue was identified (3, 4,
15, 16).
The extra-ovarian non-malignant lesions were
correctly diagnosed because of their appearance*
oblong fluid-filled tubular structures, as in hemato-
salpinx and tubo-ovarian abscesses (3, 4). In these
cases, additional clinical history and examination
were fundamental in establishing the diagnosis.
The remaining non-malignant lesions were cystic
lesions with low-signal-intensity papillary projec-
tions, homogeneous solid lesions with very low
signal intensity on T2-weighted images, and mixed
lesions with very-low-signal intensity solid compo-
nents on T2-weighted images (like striate muscle).
Our data proved that homogeneous solid lesions
with very low signal intensity on T2-weighted
images were all non-malignant. The majority of
mixed and cystic lesions with very-low-signal-
intensity components on T2-weighted images (like
striate muscle) were non-malignant. We failed only
in two borderline tumors: one borderline cystade-
nofibroma and one borderline Brenner tumor
(Table 1). These tumors may have extensive areas
of dense fibrous tissue, and have features on MRI
similar to other benign tumors with fibrous compo-
nents (16). Previous studies support the thesis that
fibromas, cystadenofibromas, and fibrothecomas
are defined by their low-signal-intensity content on
T2-weighted images. However, no previous studies
have proven that all lesions with solid components
with very low signal intensity on T2-weighted
images (such as striate muscle) could be regarded
as non-malignant (1619).
The three cystic lesions that we failed to diagnose
as non-malignant on MR were one benign struma
ovarii, one cystadenoma associated with benign
struma ovarii, and a serous cystadenoma. The two
struma ovarii were cystic lesions with septal thick-
ness ]3 mm and contrast-enhanced papillary
projections without fat component tissue signal on
MR. Our data are in line with previous studies that
have reported that some benign ovarian tumors
with enhancing solid portions such as struma ovarii
could mimic malignant lesions (15). The other cystic
lesion was a serous cystadenoma with a contrast-
enhanced papillary projection.
The four solid lesions incorrectly diagnosed as
malignant on MRI were two fibromas and one
bilateral cystadenofibroma. These lesions had little
fibrous tissue, which was not enough to produce as
low a signal as muscle on T2-weighted imaging. In
addition to the non-malignant findings referred to
above, we can conclude that when an adnexal lesion
Table 1. Adnexal lesions with low-signal-intensity solid components on T2-weighted images.
Type Fibroma Fibrothecoma Cystadenofibroma Borderline
Solid 5 1  
Cystic   5 1
Mixed 4  7 1
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has a very-low-signal-intensity solid component on
T2-weighted images, it should have fibrous tissue
in its composition. However, not all lesions
with fibrous content have low-signal-intensity solid
components on T2-weighted imaging. This feature
may result from the amount of fibrous tissue in the
adnexal lesion.
The ancillary inclusion criteria may be important,
as they increase the diagnostic confidence of malig-
nancy (15). However, caution should be used
regarding the presence of ascites. Ascites is not an
unusual finding associated with benign lesions,
mainly fibromas. In our study, contrary to the
findings of SOHAIB et al. (10), 32% of patients with
ascites had benign lesions. All patients with pelvic
adenopathies and peritoneal metastasis had malig-
nant adnexal tumors.
Our conclusions are limited by the following
factors: the patient population was previously
selected and biased by the US examination; more
benign than malignant lesions were found; the study
was retrospective; and the MR machine used was of
only intermediate strength. However, our results are
in line with previous studies performed with 1.5-
Tesla unit equipment, and 1.0-Tesla machines can
obtain similar results. Finally, because the number
of cases with very-low-signal-intensity solid compo-
nents on T2-weighted images was small, it cannot be
regarded as a statistically acceptable criterion of
non-malignancy. Nevertheless, it is our belief that
our findings are of significant importance and
should be divulged to clinicians, since they indicate
that the lesion has a high probability of being non-
malignant, with a great likelihood of being a
cystadenofibroma, fibroma, or thecoma. We also
believe that it would be important to follow up our
work with a further study to confirm our findings
through statistically acceptable data.
In conclusion, MRI has an excellent accuracy
(95%) with a high (0.92) positive predictive value
for the diagnosis of malignant adnexal lesions.
Ascites is an ancillary inclusion criterion of malig-
nancy, but is present in some (32%) benign adnexal
lesions as well.
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